Elizabeth Czerepak - 18 Nov 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc.

Role
Director
Signature
/s/ Henry Ji, Ph.D., as attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Nov 2021
Net transactions value
$0
Form type
4
Filing time
18 Nov 2021, 16:11:28 UTC
Previous filing
18 Nov 2021
Next filing
06 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 18 Nov 2021 Common Stock 100,000 $6.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the original number of shares subject to the option shall vest on December 18, 2021, and 1/12th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.